Japan BCG Laboratory
https://www.bcg.gr.jp/en/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Japan BCG Laboratory
Dainippon Sumitomo, Others Back Vaccine For TB Injectable
Dainippon Sumitomo Pharma and two other investors plan to spend $8.3 million to take shares of Create Vaccine, a Japan-based developer of tuberculosis vaccine injections, according to sources.
Sequella Inc.
Sequella Inc. believes that the technology to meet antibiotic-resistant mycobacterium tuberculosis already exists. The company will acquire intellectual property rights to product opportunities in TB.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Vaccines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice